Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy?

James V. Donadio, Eric J. Bergstralh, Douglas M. Bibus, Joseph P. Grande

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Is body size a biomarker for optimizing dosing of omega-3 polyunsaturated fatty acids in the treatment of patients with IgA nephropathy?'. Together they form a unique fingerprint.

Medicine & Life Sciences